Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Supernus Pharmaceuticals Inc (SUPN) under the Base Case is USD per share.
Compared with the current market price of 28.845 USD, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Supernus Pharmaceuticals Does
Supernus Pharmaceuticals is a specialty drug company that makes prescription medicines for central nervous system disorders, especially attention deficit hyperactivity disorder, epilepsy, migraine, and movement disorders. Its main products are branded medicines sold through pharmacies to patients with prescriptions from doctors. The company earns money when wholesalers and pharmacies buy those drugs and move them into the prescription chain.
- Headquarters
- United States of America US
- Employees
- 778
- IPO date
- Dec 28, 2010
Supernus Pharmaceuticals has no economic moat
Supernus Pharmaceuticals Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysisContinue SUPN Research
Decided on Supernus Pharmaceuticals? Get an email when SUPN reaches the price you’d buy at. Free with an account.
Other Supernus Pharmaceuticals listings
What is the Intrinsic Value of one SUPN stock?
The intrinsic value for
Supernus Pharmaceuticals Inc (SUPN) under the Base Case is USD.
Is SUPN stock undervalued or overvalued?
Compared with the current market price of 28.845 USD, the stock appears .